Infectious Disease Research Institute

Type: Organization

Name: Infectious Disease Research Institute

First reported May 13 2013 - Updated May 13 2013 - 1 reports

NanoPass Technologies Supports a CDC-Sponsored Phase 3 Study of Polio Vaccine in Infants as Part of its Global Health Initiative

/PRNewswire/ --NanoPass Technologies Ltd. ("NanoPass"), a pioneer in intradermal (into-the-skin or ID) vaccine delivery solutions, is collaborating with the US Center of Disease Control and prevention (CDC) in conducting a large phase 3 trial of polio ... [Published TickerTech.com - May 13 2013]

Entities: intradermal, Vaccine, NanoPass Technologies Ltd

First reported May 08 2013 - Updated May 08 2013 - 1 reports

IDRI moves to new HQ on Eastlake

Photos courtesy of IDRI [enlarge] The Infectious Disease Research Institute has moved into a new headquarters at 1616 Eastlake Ave. E., where it is leasing 55,000 square feet.. . . . ... [Published DJC.com - May 08 2013]

Entities: Infectious Disease Research Institute

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Investigators at Infectious Disease Research Institute Report Findings in Infectious Diseases

(NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Data detailed on Infectious Diseases have been presented. According to news reporting from Seattle, Washington, by NewsRx journalists, research stated, "Recent advances in rational ... [Published NewsRX - May 03 2013]

Entities: Infectious Disease Research Institute, Infectious Diseases, adjuvant, Vaccine, Antigen

First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Medicago, IDRI shows +ve results for bird flu vaccine

BiospectrumSingapore: Vaccine development company Medicago and Infectious Disease Research Institute (IDRI), US, reported positive interim results from a phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.The vaccine was tested in ... [Published Bio Spectrum Asia - Apr 22 2013]

Entities: Medicago, Infectious Disease Research Institute, Vaccine

First reported Apr 19 2013 - Updated Apr 20 2013 - 2 reports

Positive results for Phase I clinical trial for an H5N1 vaccine

Apr. 17, 2013 — IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical ... [Published Science Daily - Apr 20 2013]

Entities: Vaccine, Influenza A H5N1 Virus, Pandemic, Infectious Disease Research Institute

First reported Apr 17 2013 - Updated Apr 18 2013 - 6 reports

Infectious Disease Research Institute (IDRI) and Medicago, Inc. Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine

- All three configurations of adjuvant and route of administration exceeded the three CHMP criteria-SEATTLE and QUEBEC CITY, April 17, 2013 /PRNewswire-USNewswire/ --IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization ... [Published BioSpace - Apr 18 2013]

Entities: Vaccine, Infectious Disease Research Institute, Influenza A H5N1 Virus, Medicago Inc

First reported Feb 20 2013 - Updated Feb 20 2013 - 1 reports

Can Leprosy Finally Be Eradicated?

Inside the headquarters of the Infectious Disease Research Institute, senior scientist Malcolm Duthie dumps a pile of white plastic test cassettes onto a small round conference table. They are the size of flash drives and resemble pregnancy tests but ... [Published Slate Magazine - Feb 20 2013]

Entities: Leprosy, Infectious Disease Research Institute, Infusion, Protein

Quotes

But perhaps the cleverest aspect of the influenza marketing strategy surrounds the claim that "flu" and "influenza" are the same, he concludes. "All influenza is "flu," but only one in six "flus" might be influenza. It's no wonder so many people feel that "flu shots" don't work: for most flus, they can't."

Expert questions US public health agency advice on influenza vaccines [Published Brightsurf Science News - May 18 2013]

Yotam Levin, CEO of NanoPass, said, "We are delighted to support CDC as part of NanoPass's long term commitment to Global Health. We see an important opportunity for significantly reducing the dose of vaccination and hence its cost, by combining our device approach with polio vaccines. We will continue to provide access to our technology to public and private vaccine developers for Global Health applications, as we have to date with some of our partners including the Infectious Disease Research Institute (IDRI.org). The MicronJet600 device is the shortest microneedle device presently registered with FDA, and since it is about half a millimeter long it is applicable for infants as well as adults."

NanoPass Technologies Supports a CDC-Sponsored Phase 3 Study of Polio Vaccine in Infants as Part ... [Published TickerTech.com - May 13 2013]

...According to news reporting from Seattle, Washington, by NewsRx journalists, research stated, "Recent advances in rational adjuvant design and antigen selection have enabled a new generation of vaccines with potential to treat and prevent infectious disease. The aim of this study was to assess whether therapeutic immunization could impact the course of Mycobacterium tuberculosis infection with use of a candidate tuberculosis vaccine antigen, ID93, formulated in a synthetic nanoemulsion adjuvant, GLA- SE, administered in combination with... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."

Investigators at Infectious Disease Research Institute Report Findings in Infectious Diseases [Published NewsRX - May 03 2013]

...3,279,089 Commitments and contingencies Redeemable noncontrolling interests 14,534 14,564 15,610 15,817 15,819 Alexandria Real Estate Equities Inc. "s stockholders' equity: Series D Convertible Preferred Stock 250,000 250,000 250,000 250,000 250,000 Series E Preferred Stock 130,000 130,000 130,000 130,000 130,000 Common stock 633 632 632 622 616 Additional paid-in capital 3,075,860 3,086,052 3,094,987 3,053,269 3,022,242 Accumulated other comprehensive loss (22,890) (24,833) (19,729) (37,370) (23,088) Alexandria Real Estate Equities Inc." s stockholders' equity 3,433,603 3,441,851 3,455,890 3,396,521 3,379,770 Noncontrolling interests 47,144 46,643 45,120 44,247 43,413 Total equity 3,480,747...

Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2013 Financial and Op ... [Published WMCTV.com - Apr 29 2013]

More Content

sort by: Date \| Relevance
Medicago Inc. (MDG) - Pharmaceuticals & Healthc... [Published TransWorldNews - May 21 2013]
Expert questions US public health agency advice... [Published Brightsurf Science News - May 18 2013]
NanoPass Technologies Supports a CDC-Sponsored ... [Published TickerTech.com - May 13 2013]
IDRI moves to new HQ on Eastlake [Published DJC.com - May 08 2013]
Investigators at Infectious Disease Research In... [Published NewsRX - May 03 2013]
Alexandria Real Estate Equities, Inc. Reports F... [Published WMCTV.com - Apr 29 2013]
U.S. Patents Awarded to Inventors in Washington... [Published Equities.com - Apr 27 2013]
Medicago, IDRI shows +ve results for bird flu v... [Published Bio Spectrum Asia - Apr 22 2013]
Positive results for Phase I clinical trial for... [Published Science Daily - Apr 20 2013]
Phase I Trial Demonstrates Positive Results for... [Published MedIndia - Apr 19 2013]
Recently released market study: Trypanosomiasis... [Published Live-PR.com - Apr 19 2013]
Infectious Disease Research Institute (IDRI) an... [Published BioSpace - Apr 18 2013]
Phase I clinical trial for H5N1 vaccine yields ... [Published Pharmacy Choice - Apr 18 2013]
Phase I clinical trial for H5N1 vaccine yields ... [Published TruthDive - Apr 18 2013]
IDRI, Medicago announce positive Phase I clinic... [Published News-Medical.Net - Apr 18 2013]
FDA Advisory Committee Recommends Approval of B... [Published BioMedReports - Apr 18 2013]
Medicago, IDRI's vaccine trial exceeds CHMP cri... [Published Stockwatch - Apr 17 2013]
IDRI and Medicago Report Positive Results for P... [Published FinanzNachrichten.de - Apr 17 2013]
IDRI and Medicago Report Positive Results for P... [Published PR Newswire: Policy & Public Interest - Apr 17 2013]
IDRI and Medicago to present data at the World ... [Published PR Newswire: Health - Apr 09 2013]
Medicago loses $32.66-million in 2012 [Published Stockwatch - Mar 28 2013]
Can Leprosy Finally Be Eradicated? [Published Slate Magazine - Feb 20 2013]
IDRI e OrangeLife registram diagnóstico rápido ... [Published PR Newswire: Policy & Public Interest - Jan 24 2013]
IDRI And OrangeLife Register Rapid Diagnostic F... [Published PR Newswire: Policy & Public Interest - Jan 24 2013]
Reed Elsevier, HP to Launch International Healt... [Published theCSRfeed - Jan 22 2013]
Aeras and IDRI initiate tuberculosis vaccine ca... [Published PharmaBiz - Aug 24 2012]
IDRI, Medicago get US FDA clearance to begin ph... [Published PharmaBiz - Aug 18 2012]